InvestLog
DYN Dyne Therapeutics, Inc. logo

DYN Dyne Therapeutics, Inc.

Healthcare
$17.37+0.00%ClosedMarket Cap: $2.87B

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

1

Dispositions

61

Buy/Sell Ratio

0.02

Net Shares

-2,064,127

Shares Acquired

2,500

Shares Disposed

2,066,627

Total Bought ($)

$1.00

Total Sold ($)

$60.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 22Posner Brian SdirectorBuy2,500$17.1218,000
Thu May 14Lucera Erickofficer: Chief Financial OfficerSell1,448$18.36123,925
Thu May 14Kerr Douglasofficer: Chief Medical OfficerSell1,564$18.36170,042
Thu May 14Friedl-Naderer Johannaofficer: Chief Commercial OfficerSell228$18.36154,353
Thu May 14Cox Johndirector, officer: CEO & PresidentSell3,311$18.36370,834
Wed May 06Rhodes Jason PdirectorSell43,621$18.184,883,494
Wed May 06Rhodes Jason PdirectorSell21,926$18.181,549,288
Wed May 06Rhodes Jason PdirectorSell17,244$18.181,136,810
Wed May 06Rhodes Jason PdirectorSell6,241$18.004,933,196
Wed May 06Rhodes Jason PdirectorSell6,081$18.034,927,115
Wed May 06Rhodes Jason PdirectorSell3,136$18.001,574,270
Wed May 06Rhodes Jason PdirectorSell3,056$18.031,571,214
Wed May 06Rhodes Jason PdirectorSell2,466$18.001,156,457
Wed May 06Rhodes Jason PdirectorSell2,403$18.031,154,054
Wed May 06Rhodes Jason PdirectorSell61$18.008,450